Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

The University of Western Australia

ClinicalTrials.gov lists The University of Western Australia as lead sponsor of 23 trials. It has 9 approved assets.

AU Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

7 0 1995 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 6 registered with a 2026 start date. The dashed outline is the pace from the 5 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.6 trial starts a year over the five years to September, under the 5 a year the method needs. 1 trial is registered to start in 2027 or later.

This page covers The University of Western Australia: 23 lead-sponsored trials and 1 legal-entity registration.

Get the The University of Western Australia report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (75)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Obesity 7
Malaria 5
Dyslipidemias 4
Malaria, Vivax 4
Sleep Apnea Syndromes 4

Trials by start year as sponsor or collaborator (25)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 6
2025 7
2024 3
2023 5
2022 1
2021 6
2020 3
2019 3
2018 3
2017 3

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (9)

Shown in this order: max phase first.

Approved assets
Drug Trials
Atorvastatin and fenofibrate 1
Rectal tacrolimus 1
GW501516 1
Triamcinolone Acetonide 1
VERAPAMIL 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
33% hit target (n=6) 0% on time (n=6)

Journals published in (156)

Shown in this order: most published in first.

Journals published in
Journal Publications
Malaria journal 9
PloS one 7
The American journal of tropical medicine and hygiene 7
Archives of disease in childhood. Fetal and neonatal edition 5
BMJ open 5

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
106 14 2025-10-14

Financing and grant events (4)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2023-05-31 NIH grant 399,163 Reporter
2022-06-06 NIH grant 449,333 Reporter
2021-06-01 NIH grant 428,695 Reporter
2020-05-11 NIH grant 441,529 Reporter

Organization relationships (36)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Northern Territory Government of Australia Co sponsors trial with 2
National Health and Medical Research Council, Australia Co sponsors trial with 2
University of Oxford Co sponsors trial with 2
Perron Institute for Neurological and Translational Science Co sponsors trial with 1
Diabetes UK Co sponsors trial with 1

Latest dated events (183)

Shown in this order: newest first.

Latest dated events
Date Event Source
2027-02-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (49)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
G6PD Trial collaborator Named in trial inclusion criteria
G6PD Trial collaborator Named in trial inclusion criteria
G6PD Trial collaborator Named in trial inclusion criteria
GAA Trial sponsor Named in trial inclusion criteria
H6PD Trial collaborator Named in trial inclusion criteria

Biomarkers this organization publishes on (1,186)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
INS 55
IL6 34
CRP 29
APOB 28
CD4 27

On Scientist.com

The University of Western Australia is listed as a research supplier in the Scientist.com network.

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.

Work with University of Western Australia on Scientist.com

For prices, more details, or to contact University of Western Australia, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.